ALCOX:EPA
NicOx SA
€0.30
arrow_downward
-1.00%(-0.0030) 1D
Oct 19, 5:35:20 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.30
High
€0.30
Low
€0.29
Mkt. cap
29.42M
Avg. vol.
164.84K
Volume
82.39K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
99.07M
No. of employees
10
Open
€0.30
High
€0.30
Low
€0.29
Mkt. cap
29.42M
Avg. vol.
164.84K
Volume
82.39K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
99.07M
No. of employees
10
News stories
From web sources and news partners
TradingView
·
44 minutes ago
Broader S&P 500 set to outpace Mag 7 in earnings growth for first time since 2022
The Lufkin Daily News
·
55 minutes ago
Nasdaq climbs as chip and AI-linked stocks bounce back
ChartMill
·
1 hour ago
Most Active S&P 500 Stocks on Oct. 19
KuCoin
·
1 hour ago
The Dow finished last week up 0.7%. Most of the stock market
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com